CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and software solutions, today announced that revenues for the first quarter of fiscal 2009 were $89,462,000, compared to revenues in the first quarter of last year of $93,015,000, a decline of 4%. Prior-year revenues included approximately $8 million related to a contract with the State of California which was not expected to reoccur. There was a negative foreign exchange impact on revenue of almost $3 million as compared to Q1 of 2008. Net income was $2,894,000 for the quarter, compared to $3,180,000 in the prior year. Diluted earnings per share were $0.14, compared to $0.15 in the prior year. Backlog at the end of the first quarter was approximately $8.3 million.
